Skip to main content

HTG Molecular Diagnostics, Inc

HTGMDelisted Jul 10, 2023
Industry
Laboratory Analytical Instruments
SEC CIK
0001169987

HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding HTG Molecular Diagnostics, Inc changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of HTGM: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders22220
Shares2.30M606.0K−1.69M (−73.6%)
Value$3.19M$622.0K−$2.57M (−80.5%)

New holders (4)

Institutions that held HTG Molecular Diagnostics, Inc at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to HTGM in Q2 2022
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP99,054$102.0K0.00%
Two Sigma Securities, LLC57,454$59.0K0.01%
Virtu Financial LLC13,127$14.0K0.00%
Northwestern Mutual Wealth Management Co60$00.00%

Sold out (4)

Institutions that held HTG Molecular Diagnostics, Inc at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of HTGM in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Armistice Capital, LLC834,054$1.16M
Samjo Capital LLC404,963$563.0K
Cowen Prime Advisors LLC332,197$462.0K
Nantahala Capital Management, LLC285,963$397.0K